Hanada Shinichiro, Strnad Pavel, Brunt Elizabeth M, Omary M Bishr
Department of Medicine, Veterans Administration Palo Alto Health Care System and Stanford University, Palo Alto, CA, USA.
Hepatology. 2008 Sep;48(3):943-52. doi: 10.1002/hep.22436.
Mallory-Denk bodies (MDBs) are hepatocyte inclusions found in several liver diseases and consist primarily of keratins 8 and 18 (K8/K18) and ubiquitin that are cross-linked by transglutaminase-2. We hypothesized that genetic variables contribute to the extent of MDB formation, because not all patients with an MDB-associated liver disease develop inclusions. We tested this hypothesis using five strains of mice (FVB/N, C3H/He, Balb/cAnN, C57BL/6, 129X1/Sv) fed for three months (eight mice per strain) the established MDB-inducing agent 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). MDB formation was compared using hematoxylin-and-eosin staining, or immunofluorescence staining with antibodies to K8/K18/ubiquitin, or biochemically by blotting with antibodies to transglutaminase-2/p62 proteins and to K8/K18/ubiquitin to detect keratin cross-linking. DDC feeding induced MDBs in all mouse strains, but there were dramatic strain differences that quantitatively varied 2.5-fold (P < 0.05). MDB formation correlated with hepatocyte ballooning, and most ballooned hepatocytes had MDBs. Immunofluorescence assessment was far more sensitive than hematoxylin-and-eosin staining in detecting small MDBs, which out-numbered (by approximately 30-fold to 90-fold) but did not parallel their large counterparts. MDB scores partially reflected the biochemical presence of cross-linked keratin-ubiquitin species but not the changes in liver size or injury in response to DDC. The extent of steatosis correlated with the total (large+small) number of MDBs, and there was a limited correlation between large MDBs and acidophil bodies.
Mouse MDB formation has important genetic contributions that do not correlate with the extent of DDC-induced liver injury. If extrapolated to humans, the genetic contributions help explain why some patients develop MDBs whereas others are less likely to do so. Detection and classification of MDBs using MDB-marker-selective staining may offer unique links to specific histological features of DDC-induced liver injury.
马洛里-丹科小体(MDBs)是在多种肝脏疾病中发现的肝细胞内含物,主要由角蛋白8和18(K8/K18)以及通过转谷氨酰胺酶-2交联的泛素组成。我们推测基因变量会影响MDB形成的程度,因为并非所有患有与MDB相关肝脏疾病的患者都会出现内含物。我们使用五株小鼠(FVB/N、C3H/He、Balb/cAnN、C57BL/6、129X1/Sv)验证了这一假设,每株喂养三个月(每株八只小鼠)既定的MDB诱导剂3,5-二乙氧羰基-1,4-二氢可力丁(DDC)。使用苏木精-伊红染色、或用抗K8/K18/泛素抗体进行免疫荧光染色、或通过用抗转谷氨酰胺酶-2/p62蛋白以及抗K8/K18/泛素抗体进行印迹法检测角蛋白交联,比较MDB的形成情况。喂养DDC在所有小鼠品系中均诱导出MDB,但存在显著的品系差异,数量上相差2.5倍(P<0.05)。MDB的形成与肝细胞气球样变相关,大多数气球样变的肝细胞含有MDB。在检测小MDB方面,免疫荧光评估比苏木精-伊红染色敏感得多,小MDB的数量比大MDB多(约30倍至90倍),但与大MDB的变化并不平行。MDB评分部分反映了交联角蛋白-泛素物质的生化存在情况,但不能反映肝脏大小的变化或对DDC的损伤反应。脂肪变性程度与MDB的总数(大+小)相关,大MDB与嗜酸性小体之间存在有限的相关性。
小鼠MDB的形成具有重要的遗传因素,与DDC诱导的肝损伤程度无关。如果外推至人类,遗传因素有助于解释为什么一些患者会出现MDB,而另一些患者则不太可能出现。使用MDB标记选择性染色对MDB进行检测和分类,可能为DDC诱导的肝损伤的特定组织学特征提供独特的联系。